Impact of Early Respiratory Rehabilitation in the Exacerbations of Re-admitted COPD Patients

Impact of Early Respiratory Rehabilitation in the Exacerbations of Re-admitted Patients With Chronic Obstructive Pulmonary Disease (COPD)

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02190461

Enrollment

Registered

2014-07-15

Start date

2013-04-30

Completion date

2017-06-09

Last updated

2018-09-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Keywords

Early Respiratory Rehabilitation, Chronic Obstructive Pulmonary Disease, Re-admitted patients, Open clinical trial, Exacerbations

Brief summary

Open clinical trial with 1 year follow up comparing the impact of an Early Respiratory Rehabilitation program with the conventional Respiratory Rehabilitation in COPD re-admitted patients. Outcomes will be exacerbations, symptoms, functional capacity and quality of life related to health (HRQOL).

Detailed description

Open clinical trial with 1 year follow up comparing the impact of an Early Respiratory Rehabilitation (ERR) program with the conventional Respiratory Rehabilitation (CRR) in COPD re-admitted patients. Outcomes will be exacerbations, symptoms, functional capacity and quality of life related to health (HRQOL). Sixty patients will be randomized into the two groups: ERR starts the program during admission and continues at home immediately after discharge for a period of 3 months; CRR was started at home one month after discharge from hospital and continues for 3 months. Recruitment of patients and starting the RR program will occur in the first year. In the second year we will continue the intervention to those who have not completed the year. Follow-up will last until the completion of the year of all patients.

Interventions

PROCEDUREEarly Respiratory Rehabilitation Program

PROCEDUREConventional Respiratory Rehabilitation Program

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

41 Years to 110 Years

Healthy volunteers

Inclusion criteria

* Age\> 40 years * Diagnostic criteria of COPD GOLD II-IV confirmed by spirometry * Having frequent re-admissions (≥ 2 times / year). * Sign the informed consent.

Exclusion criteria

* Have completed a pulmonary rehabilitation program (including training) in the last 6 months. * Respiratory and / or cardiac serious associated diseases. * End-stage COPD (inability to perform exercises or treatment with morphine). * Prognosis of \<6 months. * Living in a residence or not having a primary caregiver. * Cognitive disorders that prevent active participation. * Patients who are admired to other hospitalization rooms than Pneumology. * Patients who do not belong to the area of health coverage of the Respiratory Rehabilitation home team

Design outcomes

Primary

Measure	Time frame	Description
Exacerbations	1 year	Exacerbations with or without admission due to respiratory illness

Secondary

Measure	Time frame	Description
Dyspnea	1 year	dyspnea in activities of daily living measured by the area of the dyspnea in the original CRQ questionnaire
Functional capacity	1 year	Exercise capacity with the six minutes walk test
Quality of life related to health	1 year	Quality of life related to health from self-administered CAT and CRC questionnaires

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026